Podcast: Understanding the Impact of Drug Induced Liver Injury on Drug Development

In this episode, Dr. Lobel talks about Drug-induced liver injury, also known as DILI. We'll cover what DILI is, how it is identified, and its effects on the clinical development process. At the end of this podcast, you'll learn where you can download a related white paper on this topic.

For more information about PPD, visit www.ppdi.com.

• Download Podcast
• Download Podcast Transcript (PDF)
• See All PharmaVOICE podcasts
• Download Companion Whitepaper - Understanding Drug-Induced Liver Injury in the Context of Pharmaceutical Development